The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 42.50, with a high estimate of 67.00 and a low estimate of 17.00. The median estimate represents a +27.21% increase from the last price of 33.41.
The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.80
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.